Jan 17,2020

Bon Secours Mercy Health and Lirio Announce Partnership and Investment

Bon Secours Mercy Health and Lirio, LLC announced their new strategic partnership at the 38th annual J.P. Morgan Healthcare Conference, initiated by a direct investment from Bon Secours Mercy Health in Lirio’s innovative behavior change AI platform.

COLLABORATION PARTNERSHIP

#product & service

View Analyst & Ambassador Comments
Go to original news
Mar 02,2020

With Beurer to the blood pressure measurement specialist

Under the motto "Become a blood pressure measurement specialist", Beurer is presenting its new e-training course, which was created in cooperation with the German Hypertension League Pharmacists are rewarded with two continuing education points.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Mar 26,2020

DarioHealth® Announces Key New Hires Expanding Its Management Depth in the Employer and Managed Care Markets

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Omar Manejwala, M.D to the newly created position of Chief Medical Officer, and Barbara Stark as Senior Vice President and Head of Managed Markets. These two appointments provide decades of industry and clinical experience to the managed care and clinical support teams.

View Analyst & Ambassador Comments
Go to original news
Apr 07,2020

Livongo stock jumps over 10 percent on revised earnings guidance, pointing to digital health boom

Livongo Health’s stock jumped over ten percent on a day that saw most exchanges tumble after a day of crazy volatility.

View Analyst & Ambassador Comments
Go to original news
Apr 08,2020

One Drop Announces Launch of SugarRx

One Drop, a leader in digital therapeutics solutions for people living with diabetes and other chronic conditions, today announced the launch of SugarRx, a digital subscription for personal diabetes coaching and education, delivered entirely in the award-winning One Drop app.

PRODUCT

#coaching

View Analyst & Ambassador Comments
Go to original news
Apr 13,2020

One Drop Acquires Sano

One Drop, a leader in digital care solutions for people living with diabetes and other chronic conditions, today announced it has acquired all of the assets and intellectual property of Sano Intelligence, Inc., an innovator in health sensing technology.

COLLABORATION MERGERS & ACQUISITION

#product & service

#rpm

View Analyst & Ambassador Comments
Go to original news
Apr 23,2020

COVID-19: A GP’s tips for those living with chronic conditions

Dr Roger Henderson, GP and UK medical director at Liva Healthcare, shares his advice for people with underlying health conditions during the coronavirus pandemic.

View Analyst & Ambassador Comments
Go to original news
Apr 29,2020

DarioHealth Expands Remote Care Offering With Integration of Full-Service Telemedicine

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in global digital therapeutics (DTx), announced today a new partnership with value-based telemedicine provider MediOrbis to expand Dario's existing service offering with a full suite of telemedicine capabilities for its 50,000 active users.

COLLABORATION PARTNERSHIP

#product & service

#telehealth

View Analyst & Ambassador Comments
Go to original news
May 14,2020

Hypertension patients with comorbidity establish reduction in blood pressure levels with digital therapeutic intervention

Wellthy Therapeutics presented their real-world evidence on how participants with hypertension, along with a comorbidity, established a significant reduction in blood pressure levels with the help of a digital therapeutic intervention. A retrospective analysis of comorbidity levels like blood sugar also showed positive results.

CLINICAL STUDY

#dtx

View Analyst & Ambassador Comments
Go to original news
Jun 15,2020

DarioHealth Presents New Studies Demonstrating Sustained Improvements in Blood Glucose and Blood Pressure Control in Users with Diabetes and Hypertension at the American Diabetes Association's 80th Scientific Sessions

Demonstrated a eA1c reduction of 1.42% which was sustained for two years

CLINICAL STUDY

#dtx

View Analyst & Ambassador Comments
Go to original news
Subscribe to HYPERTENSION